NIH Releases Mpox Research Agenda - National Institute of Allergy …
WEB4 days ago · As part of the U.S. government response to the current mpox outbreak, the National Institutes of Health’s (NIH) National Institute of Allergy and Infectious Diseases (NIAID) has released an update on its priorities for mpox research DOC. The NIAID mpox research agenda focuses on four key objectives: increasing knowledge about the biology of ...
Newsroom - National Institute of Allergy and Infectious Diseases …
WEBAug 22, 2024 · Newsroom | NIAID: National Institute of Allergy and Infectious Diseases. News & Events. Newsroom. Latest News Releases. NIH Awards Will Support Innovation in Syphilis Diagnostics. September 03, 2024. The Antiviral Tecovirimat is Safe but Did Not Improve Clade I Mpox Resolution in Democratic Republic of the Congo. August 15, 2024.
New director named at National Institute of Allergy and Infectious ...
WEBAug 2, 2023 · Dr. Jeanne Marrazzo will be the next director of the National Institute of Allergy and Infectious Diseases, the National Institutes of Health announced Wednesday. Marrazzo is expected to...
NIH awards establish pandemic preparedness research network
WEBSep 13, 2024 · NIAID. The National Institutes of Health (NIH) has established a pandemic preparedness research network to conduct research on high-priority pathogens most likely to threaten human health with the goal of developing effective vaccines and monoclonal antibodies. Currently, many of the diseases caused by …
NIH launches clinical trials network to test COVID-19 vaccines …
WEBJul 8, 2020 · The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has established a new clinical trials network that aims to enroll thousands of volunteers in large-scale clinical trials testing a variety of investigational vaccines and monoclonal antibodies intended to protect people from COVID-19.
NIH clinical trial shows Remdesivir accelerates recovery from …
WEBApr 29, 2020 · Hospitalized patients with advanced COVID-19 and lung involvement who received remdesivir recovered faster than similar patients who received placebo, according to a preliminary data analysis from a randomized, controlled trial involving 1063 patients, which began on February 21.
Clinical Trial of mRNA Universal Influenza Vaccine Candidate Begins
WEBMay 15, 2023 · A clinical trial of an experimental universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC), part of the National Institutes of Health, has begun enrolling volunteers at Duke University in Durham, North Carolina.
Fall is approaching, but mosquito season isn't over - NBC News
WEB2 days ago · In perhaps the most public case of West Nile this year, Dr. Anthony Fauci, former director of the National Institute of Allergy and Infectious Diseases, was hospitalized in August then sent home ...
Anthony Fauci recovering after hospitalization for West Nile ... - ABC News
WEBAug 24, 2024 · Dr. Anthony Fauci, the former director of the National Institute of Allergy and Infectious Diseases, was hospitalized with a case of West Nile virus and is now recovering at home, a spokesperson said.
Anthony Fauci to step down in December as Biden's lead ... - NBC News
WEBAug 22, 2022 · Dr. Anthony Fauci will leave as director of the National Institute of Allergy and Infectious Diseases and as chief medical adviser to President Joe Biden in December, Fauci announced Monday.